Modeling the lymph node stromal cells in oral squamous cell carcinoma: insights into the stromal cues in nodal metastasis
- PMID: 39760828
- DOI: 10.1007/s13577-024-01166-8
Modeling the lymph node stromal cells in oral squamous cell carcinoma: insights into the stromal cues in nodal metastasis
Abstract
The study explores the development and characterization of lymph node stromal cell cultures (LNSCs) from patients with oral squamous cell carcinoma (OSCC), highlighting the importance of understanding tumor-node cross-talk for effective prognostic and therapeutic interventions. Herein, we describe the development and characterization of primary lymph node stromal cells (LNSCs, N = 14) from nodes of metastatic and non-metastatic OSCC patients. Primary cultures were established by the explant method from positive (N + ; N = 2), and negative nodes (N0m; N = 4) of the metastatic patients (N = 3) as well as negative (N0nm; N = 8) nodes from non-metastatic (N = 4) patients. STR profiling confirmed the purity and novelty, while characterization by immunocytochemistry/flow cytometry revealed heterogeneous cell populations consisting of fibroblastic reticular cells (CD31-Gp38 +) and double negative cells (CD31-Gp38-). Transcriptomic profiling indicated molecular alterations in the cells based on the non-metastatic, the pre-metastatic or metastatic status of the nodes, pro-inflammatory, matrix remodeling, and immune evasion being the primary pathways. Assessment of the protein levels for five selected markers (MX1, ISG15, CPM, ITGB4 and FOS) in the cell lines revealed that CPM levels were significantly reduced in the N + and N0m nodes whereas ISG15 levels reduced in N0m. Significantly, the profiling also provided insights into possible glycosylation of CPM (N0nm) and ISGylation of ISG15 (N0m). Cytokine profiling indicated release of chemokines/anti-proliferative cytokines from the negative nodes, while angiogenic/pro-metastatic cytokines were released from the nodes of metastatic patients. The lymph node stromal cell models established in the study with distinctive transcriptomic/cytokine characteristics will be invaluable in delineating the processes underlying nodal metastasis.
Keywords: Lymph node metastasis; Lymph node stromal cells; Nodal metastasis; Oral squamous cell carcinoma; Pre-metastatic niche.
© 2025. The Author(s) under exclusive licence to Japan Human Cell Society.
Conflict of interest statement
Declarations. Conflicts of interest: The authors declare they have no conflict of interest in the subject matter discussed in this manuscript. Ethics approval: The study was approved by the institutional ethical committee: Narayana health medical ethics committee (NHH/MEC-CL-EL-6–2016-403(A-1)). Informed consent: The samples were collected after obtaining written informed consent from the patients.
Similar articles
-
Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.Oncol Rep. 2007 Nov;18(5):1107-13. Oncol Rep. 2007. PMID: 17914560
-
[Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].Ai Zheng. 2005 Feb;24(2):208-12. Ai Zheng. 2005. PMID: 15694035 Chinese.
-
Revelation of comprehensive cell profiling of primary and metastatic tumour ecosystems in oral squamous cell carcinoma by single-cell transcriptomic analysis.Int J Med Sci. 2024 Aug 26;21(12):2293-2304. doi: 10.7150/ijms.97404. eCollection 2024. Int J Med Sci. 2024. PMID: 39310253 Free PMC article.
-
The ending is not the end: Lymph node metastasis in oral squamous cell carcinoma.Int Immunopharmacol. 2025 Jan 27;146:113917. doi: 10.1016/j.intimp.2024.113917. Epub 2024 Dec 24. Int Immunopharmacol. 2025. PMID: 39721451 Review.
-
Extranodal extension in oral cancer: A role for the nodal microenvironment?J Oral Pathol Med. 2019 Nov;48(10):863-870. doi: 10.1111/jop.12870. Epub 2019 May 21. J Oral Pathol Med. 2019. PMID: 31087397 Review.
References
-
- Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115(24):5700–10. https://doi.org/10.1002/cncr.24631 . - DOI
-
- Thavarool SB, Muttath G, Nayanar S, Duraisamy K, Bhat P, Shringarpure K, et al. Improved survival among oral cancer patients: findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India. World J Surgical Oncol. 2019;17(1):15. https://doi.org/10.1186/s12957-018-1550-z . - DOI
-
- Geum DH, Roh YC, Yoon SY, Kim HG, Lee JH, Song JM, et al. The impact factors on 5-year survival rate in patients operated with oral cancer. J Korean Assoc Oral Maxillofac Surg. 2013;39(5):207–16. https://doi.org/10.5125/jkaoms.2013.39.5.207 . - DOI
-
- Thierry GR, Gentek R, Bajenoff M. Remodeling of reactive lymph nodes: dynamics of stromal cells and underlying chemokine signaling. Immunol Rev. 2019;289(1):42–61. https://doi.org/10.1111/imr.12750 . - DOI
-
- Martinez VG, Pankova V, Krasny L, Singh T, Makris S, White IJ, et al. Fibroblastic reticular cells control conduit matrix deposition during lymph node expansion. Cell reports. 2019;29(9):2810-22 e5. https://doi.org/10.1016/j.celrep.2019.10.103 . - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous